November 18th 2024
More than half of US adults—approximately 137 million—are candidates for semaglutide based on diabetes, weight management, or cardiovascular prevention indications.
November 16th 2024
Improving Quality of Care with Electronic Glycemic Management Systems
At AACE 2017, Jagdeesh Ullal, MD, MS, Eastern Virginia Medical School discussed data from his team’s study that assessed the efficacy of an electronic glycemic management system (eGlycemic Management) management in controlling blood sugars in the hospital setting.
Diabetes: Never Fail to Examine The Foot
According to Andrew Boulton, MD, University of Manchester, UK, University of Miami, Florida, the most important take home message for doctors regarding the diabetic foot and reducing amputations, is to remove their patients’ shoes and socks and look at their feet.
Diabetes Care: The Challenges of Fasting and Feasting
At AACE 2017, Shashank Joshi, MD, Lilavati Hospital and Research Centre, Mumbai explained his team’s simple diabetes treatment formula: A for A1C, B for blood pressure, C for cholesterol (LDL cholesterol), and D for diet that’s culturally sensitive and adaptable.